114 related articles for article (PubMed ID: 21553905)
1. Vibrational softening of a protein on ligand binding.
Balog E; Perahia D; Smith JC; Merzel F
J Phys Chem B; 2011 Jun; 115(21):6811-7. PubMed ID: 21553905
[TBL] [Abstract][Full Text] [Related]
2. Theory and normal-mode analysis of change in protein vibrational dynamics on ligand binding.
Moritsugu K; Njunda BM; Smith JC
J Phys Chem B; 2010 Jan; 114(3):1479-85. PubMed ID: 20043649
[TBL] [Abstract][Full Text] [Related]
3. Conformational heterogeneity and low-frequency vibrational modes of proteins.
Balog E; Smith JC; Perahia D
Phys Chem Chem Phys; 2006 Dec; 8(47):5543-8. PubMed ID: 17136269
[TBL] [Abstract][Full Text] [Related]
4. Direct determination of vibrational density of states change on ligand binding to a protein.
Balog E; Becker T; Oettl M; Lechner R; Daniel R; Finney J; Smith JC
Phys Rev Lett; 2004 Jul; 93(2):028103. PubMed ID: 15323955
[TBL] [Abstract][Full Text] [Related]
5. Neutron diffraction studies of Escherichia coli dihydrofolate reductase complexed with methotrexate.
Bennett B; Langan P; Coates L; Mustyakimov M; Schoenborn B; Howell EE; Dealwis C
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18493-8. PubMed ID: 17130456
[TBL] [Abstract][Full Text] [Related]
6. Towards understanding the mechanisms of molecular recognition by computer simulations of ligand-protein interactions.
Verkhivker GM; Rejto PA; Bouzida D; Arthurs S; Colson AB; Freer ST; Gehlhaar DK; Larson V; Luty BA; Marrone T; Rose PW
J Mol Recognit; 1999; 12(6):371-89. PubMed ID: 10611647
[TBL] [Abstract][Full Text] [Related]
7. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
Senkovich O; Schormann N; Chattopadhyay D
Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
[TBL] [Abstract][Full Text] [Related]
8. High-mannose-type glycan modifications of dihydrofolate reductase using glycan-methotrexate conjugates.
Totani K; Matsuo I; Ihara Y; Ito Y
Bioorg Med Chem; 2006 Aug; 14(15):5220-9. PubMed ID: 16647263
[TBL] [Abstract][Full Text] [Related]
9. Designing protein dimerizers: the importance of ligand conformational equilibria.
Carlson JC; Kanter A; Thuduppathy GR; Cody V; Pineda PE; McIvor RS; Wagner CR
J Am Chem Soc; 2003 Feb; 125(6):1501-7. PubMed ID: 12568609
[TBL] [Abstract][Full Text] [Related]
10. Tight binding ligand approach to oligosaccharide-grafted protein.
Totani K; Matsuo I; Ito Y
Bioorg Med Chem Lett; 2004 May; 14(9):2285-9. PubMed ID: 15081026
[TBL] [Abstract][Full Text] [Related]
11. Influence of pressure on the low-frequency vibrational modes of lysozyme and water: a complementary inelastic neutron scattering and molecular dynamics simulation study.
Lerbret A; Hédoux A; Annighöfer B; Bellissent-Funel MC
Proteins; 2013 Feb; 81(2):326-40. PubMed ID: 23011876
[TBL] [Abstract][Full Text] [Related]
12. Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH.
Cody V; Luft JR; Pangborn W
Acta Crystallogr D Biol Crystallogr; 2005 Feb; 61(Pt 2):147-55. PubMed ID: 15681865
[TBL] [Abstract][Full Text] [Related]
13. Preliminary neutron diffraction studies of Escherichia coli dihydrofolate reductase bound to the anticancer drug methotrexate.
Bennett BC; Meilleur F; Myles DA; Howell EE; Dealwis CG
Acta Crystallogr D Biol Crystallogr; 2005 May; 61(Pt 5):574-9. PubMed ID: 15858267
[TBL] [Abstract][Full Text] [Related]
14. The crystal structure of dihydrofolate reductase from Thermotoga maritima: molecular features of thermostability.
Dams T; Auerbach G; Bader G; Jacob U; Ploom T; Huber R; Jaenicke R
J Mol Biol; 2000 Mar; 297(3):659-72. PubMed ID: 10731419
[TBL] [Abstract][Full Text] [Related]
15. A 2.13 A structure of E. coli dihydrofolate reductase bound to a novel competitive inhibitor reveals a new binding surface involving the M20 loop region.
Summerfield RL; Daigle DM; Mayer S; Mallik D; Hughes DW; Jackson SG; Sulek M; Organ MG; Brown ED; Junop MS
J Med Chem; 2006 Nov; 49(24):6977-86. PubMed ID: 17125251
[TBL] [Abstract][Full Text] [Related]
16. Effect of ligand binding on the intraminimum dynamics of proteins.
Alakent B; Baskan S; Doruker P
J Comput Chem; 2011 Feb; 32(3):483-96. PubMed ID: 20730777
[TBL] [Abstract][Full Text] [Related]
17. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase.
Bennett BC; Xu H; Simmerman RF; Lee RE; Dealwis CG
J Med Chem; 2007 Sep; 50(18):4374-81. PubMed ID: 17696333
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs.
Al-Rashood ST; Aboldahab IA; Nagi MN; Abouzeid LA; Abdel-Aziz AA; Abdel-Hamide SG; Youssef KM; Al-Obaid AM; El-Subbagh HI
Bioorg Med Chem; 2006 Dec; 14(24):8608-21. PubMed ID: 16971132
[TBL] [Abstract][Full Text] [Related]
20. Role of ionic interactions in ligand binding and catalysis of R67 dihydrofolate reductase.
Hicks SN; Smiley RD; Hamilton JB; Howell EE
Biochemistry; 2003 Sep; 42(36):10569-78. PubMed ID: 12962480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
